A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
Author:
Publisher
Korean Cancer Association
Subject
Cancer Research,Oncology
Link
http://e-crt.org/upload/pdf/crt-2018-379.pdf
Reference24 articles.
1. Colorectal cancer statistics, 2017
2. An Update on Treatment Advances for the First-Line Therapy of Metastatic Colorectal Cancer
3. VEGF as a Key Mediator of Angiogenesis in Cancer
4. Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Are statins onco- suppressive agents for every type of tumor? A systematic review of literature;Expert Review of Anticancer Therapy;2024-04-15
2. New insights into the therapeutic potentials of statins in cancer;Frontiers in Pharmacology;2023-07-07
3. A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors;Pediatric Blood & Cancer;2023-05-09
4. Therapeutic Effects of Statins: Promising drug for Topical and Transdermal Administration;Current Medicinal Chemistry;2023-05-08
5. Celecoxib and bevacizumab synergistically inhibit non-small cell lung cancer by inducing apoptosis and modulating VEGF and MMP-9 expression;PAK J PHARM SCI;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3